August 2006 « Chantix News HomePfizer's Chantix(TM) (varenicline) Now Available to help smokers quit Chantix was developed by Pfizer and it is the first new prescription aid to smoking Cessation approved by the FDA in nearly a decade in two head-to-head, Placebo-Controlled Studies, about 44% of patients who took chantix quit smoking by the end of 12 weeks of treatment. About 30% of patients who took Buproprion SR and about 18% who tool a sugar pill quit by the end of the same 12-week Treatment period. DR. MITCHELL NIDES, A SMOKING CESSATION SPECIALIST, COMMENTS ON CHANTIX: "Quitting smoking is tough, largely due to nicotine addiction. It often takes smokers several times before they're successful. The approval of Chantix offers new hope to those who've tried unsuccessfully in the past, as well as those who've never tried before. My hope is that it will successfully help many people quit smoking." Read More: http://biz.yahoo.com/prnews/060807/mvm016.html?.v=1 |
|
Home
| Chantix News | Quit
Smoking Articles | Disclaimer |